#microfluidizer

[high-pressure-homogenizer]

UltraGenizer High Shear Homogenizer:UltraGenizer is a laboratory ultra high pressure processing device. It is an electrically-driven and bench-top high shear homogenizer, which requires no compressed air or hydraulic oil to achieve maximum 4,200 bar (60,000 psi) operating pressure.

Application of UltraGenizer High Shear Homogenizer:Nano emulsions  Nano dispersions Liposomes Nanoparticles Graphene Deagglomeration 

Performance of UltraGenizer High Shear Homogenizer:Energy efficient, 1/2 energy loss of the most homogenizers Small (integrated design delivers the light weight and small dimensions) Smart (programming control systems confer diligent functions: controlled inlet volume ± 0.1mL; auto stop with time/volume) Silent (noiseless performance) Strong (more than 150 mL/min at 60,000 psi) CE compliant and RoHs compliant

[fuckyeahfluiddynamics]

Blood Flow in a Fin

This award-winning video shows blood flowing through the tail fin of a small fish. Cells flow outward in a central vessel, then split to either side for the return journey. (Video and image credit: F. Weston for the 2023 Nikon Small World in Motion Competition; via Colossal) Read the full article

[bpod-bpod]

Rooting for You

Deep underground, bargains are made between living things. Symbiotic relationships allow fungi to weave their whisker-like hyphae among the roots of plants. This is mutually beneficial: the fungus is rewarded with nutrients while expanding the plant’s thirsty root system. But this biological bonding might benefit us too. Here, researchers grow a plant in a pit of sandy silica nanoparticles. Its roots burrow tunnels in the particles which then harden after a blast of extreme heat, a process known as sintering which leaves a network of tiny channels behind in the transformed glass. A blue liquid is sucked through the tunnels via capillary action, similar to how chemicals move into and around our tissues. Such techniques might allow tissue engineers to explore new designs for microfluidic devices, using plants and fungi as tiny biodegradable scaffolds.

Written by John Ankers

Clip from a video from work by Tetsuro Koga, Shota Nakashima & Fujio Tsumori

Department of Aeronautics and Astronautics, Graduate School of Kyushu University, Fukuoka, Japan

Video originally published with a Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0)

Published in Scientific Reports, September 2024

You can also follow BPoD on Instagram, Twitter, Facebook and Bluesky

[materialsscienceandengineering]

Collective synchronized magnetic oscillations enable micropillar arrays to manipulate fluids and act as soft robots

Researchers from Hanyang University have developed an innovative micropillar array capable of collective and rapid magnetic oscillations, demonstrating strong potential for advanced applications in robotics, fluid transport, and dynamic surface control. In nature, many organisms exhibit collective movements to accomplish tasks that would be challenging for individuals alone. A prominent example is the coordinated motion of marine cilia, which collectively regulate fluid flow, facilitate locomotion, or enhance adhesion to surrounding surfaces. Although artificial micropillar structures have been explored to manipulate surface functionality, achieving dynamic actuation with both rapid response and sufficiently large deformation remains a significant challenge.

Read more.

[mattgrayyes]

I can't remember when I last spend a whole day going wow like this, the research has got so much further than I'd have expected!

Matt Gray is Trying: Biomedical Research

[innonurse]

Microfluidic organ chip replicates human cervix, addressing critical gap in women's health research

- By InnoNurse Staff -

Bacterial vaginosis (BV) affects over 25% of reproductive-aged women, causing severe health complications, and is inadequately treated by current antibiotics, prompting researchers at Harvard and UC Davis to develop a microfluidic "Cervix Chip" that models the cervix's complex environment to better study BV and improve treatments.

Read more at Harvard University/Medical Xpress

Header image credit: DALL·E 3

[microscope-world]

Microfluidics under the ZEISS Stemi 508 microscope.

[healthdivine]

🧪💡 Tiny tech, massive impact! Micro pumps are powering precision in drug delivery, diagnostics & wearables 📦

[thelovebudllc]

New microfluidic device brings affordable kidney testing to the point of care

Chronic kidney disease (CKD) affects over 800 million people globally and is often diagnosed too late for effective intervention. Early detection depends on accurate measurement of biomarkers such as creatinine and the urine albumin-to-creatinine ratio (uACR). While urine testing is non-invasive and informative, standard methods are time-consuming, costly, and require specialized facilities.…

[johniac]

SciTech Chronicles. . . . . .May 16th, 2025

[materialsscienceandengineering]

An electrospray engine applies an electric field to a conductive liquid, generating a high-speed jet of tiny droplets that can propel a spacecraft. These miniature engines are ideal for small satellites called CubeSats that are often used in academic research. Since electrospray engines utilize propellant more efficiently than the powerful, chemical rockets used on the launchpad, they are better suited for precise, in-orbit maneuvers. The thrust generated by an electrospray emitter is tiny, so electrospray engines typically use an array of emitters that are uniformly operated in parallel. However, these multiplexed electrospray thrusters are typically made via expensive and time-consuming semiconductor cleanroom fabrication, which limits who can manufacture them and how the devices can be applied.

Read more.

[nuadox]

3D-printed collagen scaffolds mimic living tissues and may replace animal testing

- By Nuadox Crew -

Engineers at the University of Pittsburgh have developed a groundbreaking method for 3D printing collagen-based scaffolds—called CHIPS—that support the growth and self-organization of living cells into functional tissues.

Led by Daniel Shiwarski in collaboration with Adam Feinberg from Carnegie Mellon, this innovation combines natural biomaterials with advanced microfluidic design to mimic real organ environments.

Unlike traditional synthetic models, these collagen structures allow cells to grow, interact, and function as they would in the body, including responding to stimuli like glucose.

Integrated with a custom bioreactor system (VAPOR), the platform enables complex 3D vascular networks and offers a more human-relevant alternative to animal testing.

All designs are open-source, with the long-term goal of modeling diseases like hypertension and replacing animal studies in biomedical research.

Header image: Online cover of Science Advances, April issue. Credit: Daniel Shiwarski.

Read more at University of Pittsburgh Swanson School of Engineering

Scientific paper: “3D bioprinting of collagen-based high-resolution internally perfusable scaffolds for engineering fully biologic tissue systems” by Daniel J. Shiwarski, Andrew R. Hudson, Joshua W. Tashman, Ezgi Bakirci, Samuel Moss, Brian D. Coffin and Adam W. Feinberg, 23 April 2025, Science Advances. DOI: 10.1126/sciadv.adu5905

Related Content

Scientists achieve the milestone of being the first to successfully 3D-print functional human brain tissue

Other Recent News

Household washing machines may leave behind harmful pathogens on clothing.

Facial and eye biomarkers reveal new insights into tinnitus severity, offering potential for treatment testing.

Uncovered mechanisms improve understanding of advanced AI memory devices.

One molecule significantly enhances both the efficiency and durability of perovskite solar cells.

[agaselectronicmaterials]

Negative Photoresists: Tailored Solutions for Complex Designs

Explore how negative photoresists deliver precision, durability, and high aspect ratio patterning for electronics, MEMS, photonics, and PCB manufacturing. Discover tailored solutions for microfabrication excellence with A-Gas Electronic Materials. Contact us today to learn more.

[beurich]

Der Mikrofluidik-Markt soll bis 2032 ein Volumen von 72,37 Milliarden US-Dollar erreichen

Es  wird erwartet, dass der globale Markt für Mikrofluidik zwischen 2025 und 2032 ein starkes Wachstum verzeichnen wird, das durch Fortschritte im Gesundheitswesen, in der Biotechnologie und in der Diagnostik angetrieben wird. Die Mikrofluidik-Technologie, bei der Flüssigkeiten auf der Mikroebene manipuliert werden, verändert zahlreiche Branchen, indem sie Prozesse ermöglicht, die effizienter,…

[skyquest-market-research]

Microfluidics Market to Reach $72.37 Billion by 2032, Driven by Innovation and Healthcare Demand

The global microfluidics market is expected to witness strong growth between 2025 and 2032, fueled by advancements in healthcare, biotechnology, and diagnostics. Microfluidics technology, which involves the manipulation of fluids at the microscale level, is transforming numerous industries by enabling processes that are more efficient, cost-effective, and precise.

Microfluidics Market is projected to expand from USD 27.61 billion in 2024 to USD 72.37 billion by 2032, registering a compound annual growth rate (CAGR) of 12.8% during the forecast period (2025–2032).

Microfluidics allows the controlled movement of small fluid volumes in micro-scale channels and plays a vital role in applications like lab-on-a-chip systems, diagnostics, drug development, and chemical synthesis. The post-COVID-19 era has particularly accelerated the demand for rapid and accurate diagnostic solutions, contributing to market expansion. Moreover, microfluidics is gaining prominence in clinical diagnostics, biomedical research, and pharmaceutical development due to its ability to execute complex tests on a compact chip.

Request Sample of the Report - https://www.skyquestt.com/sample-request/microfluidics-market

Key Growth Drivers:

Technological Advancements: Innovations such as new materials, integration with AI and nanotechnology are driving market growth. These improvements are enhancing sensor sophistication, enabling lab miniaturization, and improving diagnostics and drug delivery capabilities.

Growing Demand for Point-of-Care Diagnostics: As the need for rapid, low-cost diagnostics increases—particularly in healthcare—microfluidic devices are gaining popularity. These systems enable immediate testing and improve clinical decision-making timelines.

Rise in Chronic Diseases: With increasing cases of chronic illnesses such as cancer, cardiovascular conditions, and diabetes, there is a greater need for microfluidic devices for early diagnosis, personalized therapies, and targeted drug delivery.

Government Investments: Governments around the world are increasing funding for healthcare, life sciences, and diagnostic research, further supporting the adoption of microfluidic technologies in labs and clinics.

Challenges and Restraints:

High Manufacturing Costs: Producing microfluidic systems involves significant costs due to the intricacy of design and the challenges of scaling production, making widespread adoption difficult in cost-sensitive regions.

Regulatory Hurdles: Medical applications of microfluidics must pass stringent regulatory approvals, leading to extended time-to-market and additional financial burdens.

Technical Limitations: Ensuring consistent performance, scaling up for mass production, and integrating with other technologies remain technical hurdles for device manufacturers.

Get Customized Reports with Your Requirements - https://www.skyquestt.com/speak-with-analyst/microfluidics-market

Segmentation Analysis:

The microfluidics market is segmented by product type, application, end-user, and region:

By Product Type

Microfluidic Chips – Core for diagnostics, drug delivery, and R&D

Micro Pumps & Valves – Essential for precise fluid control

Sensors & Others – Includes pressure, temperature, and related sensors

By Application

Diagnostics – Widely applied in clinical testing, including genetic analysis and immunoassays

Drug Development – Crucial for high-throughput screening and drug formulation

Environmental Monitoring – Used in real-time analysis of air and water quality

By End-User

Healthcare Providers – Hospitals and diagnostic labs using microfluidics for on-site testing

Research Institutions – Utilize microfluidics in chemical analysis and drug discovery

Pharmaceuticals & Biotechnology Firms – Employ microfluidic platforms for research and product development

By Region

North America – Leads the market due to advanced R&D and healthcare infrastructure

Europe – Growing steadily with rising adoption in biotech and diagnostics

Asia-Pacific – Poised for fastest growth due to healthcare development and cost-effective solutions

Rest of the World – Includes growth potential in Latin America, the Middle East, and Africa

Read More for a Deeper Understanding - https://www.skyquestt.com/report/microfluidics-market

Key Players in the Market:

Leading companies in the microfluidics sector include:

Thermo Fisher Scientific Inc.

Danaher Corporation

Abbott Laboratories

PerkinElmer Inc.

Bio-Rad Laboratories, Inc.

Dolomite Microfluidics

Fluidigm Corporation

Idex Corporation

Schott AG

These companies are heavily investing in research and development to enhance their product offerings and expand their market reach.

Future Outlook:

From 2025 to 2032, the microfluidics market is expected to see robust growth fueled by rising healthcare needs, continuous technological innovation, and growing demand for point-of-care diagnostics. Although challenges such as manufacturing costs and regulatory requirements exist, the overall outlook is highly positive. As the biotechnology and healthcare sectors continue to evolve, microfluidics will remain essential to progress in diagnostics, drug development, and personalized medicine.

[thelovebudllc]

Microfluidic contact lenses emerge as next generation tools for eye care

The tear film coating the eye offers a window into a person’s systemic and ocular health, carrying biomarkers such as glucose, electrolytes, and proteins. Yet, existing diagnostic approaches-like tonometry or tear sampling-are often invasive, infrequent, and impractical for daily monitoring. Likewise, standard eye drop treatments suffer from poor drug retention due to blinking and drainage,…